Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Short Interest Up 8.9% in December
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) was the target of a significant growth in short interest during ...
Business Wire10d
Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025
Such forward-looking statements include, among other things, statements regarding the potential of, and expectations regarding, Edgewise’s product candidates and programs, including sevasemten ...
Business Wire1mon
Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)
Edgewise’s product candidates and programs, including sevasemten (EDG-5506) and EDG-7500; statements regarding Edgewise’s milestones; statements regarding whether data from the GRAND CANYON ...
Stockhouse10d
Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025
Such forward-looking statements include, among other things, statements regarding the potential of, and expectations regarding, Edgewise’s product candidates and programs, including ...